Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer's disease

Neurodegenerative diseases are a growing burden, and there is an urgent need for better biomarkers for diagnosis, prognosis, and treatment efficacy. Structural and functional brain alterations are reflected in the protein composition of cerebrospinal fluid (CSF). Alzheimer's disease (AD) patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Bader, Jakob M, Geyer, Philipp E, Müller, Johannes B, Strauss, Maximilian T, Koch, Manja, Leypoldt, Frank, Koertvelyessy, Peter, Bittner, Daniel, Schipke, Carola G, Incesoy, Enise I, Peters, Oliver, Deigendesch, Nikolaus, Simons, Mikael, Jensen, Majken K, Zetterberg, Henrik, Mann, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7266499/
https://www.ncbi.nlm.nih.gov/pubmed/32485097
http://dx.doi.org/10.15252/msb.20199356

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7266499/
https://www.ncbi.nlm.nih.gov/pubmed/32485097
http://dx.doi.org/10.15252/msb.20199356

Ejemplares similares